|OMB APPROVAL                                                                                          
|------------------------------------------------------------------------------------------------------
|OMB Number: 3235-0416
Expires: February 28, 2006
Estimated average burden
hours per response    182.00



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 10-QSB



QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934





FOR THE PERIOD ENDED: September 30, 2003



COMMISSION FILE NUMBER: 333-06718



VIROPRO INC.

------------------------------------------------------

(Exact name of registrant as specified in its charter)





NEVADA

13-3124057

----------------------------------------------------

--------------------

(State or other jurisdiction of

(IRS Employer

incorporation or organization)

Identification No.)



3163 Kennedy Boulevard, Jersey City, New Jersey 07306

------------------------------------------------------------

(Address, including zip code, of principal executive offices)



(201) 217-4137

---------------------------------------------------

(Registrant's telephone number, including area code)



N/A

------------------------------------------------------------------------

(Former name, former address & former fiscal year, if changed since last report)



Indicate by check  mark whether the  registrant (1) has filed all  documents and reports required to be filed by Sections 13 or 15(d) of  the Securities Exchange Act of 1934 during the preceding  12 months (or for such shorter period that the registrant was required to  file such reports), and (2) has been subject to such filings for the past 90 days.     YES  (X)    NO  ()



APPLICABLE ONLY TO CORPORATE ISSUERS:



As of September 30, 2003, the number of the Company's shares of par value $.001 common stock outstanding was 49,974,749.



SEC 2334 (8-03)

Potential persons who are to respond to the collection of information contained in this form are not

required  to  respond unless the  form displays a currently valid OMB control number.

---

VIROPRO, INC.

FORM 10-QSB

September 30, 2003





INDEX



PART I - FINANCIAL INFORMATION



Consolidated Balance Sheet

3



Consolidated Statements of Operation

4



Consolidated Statements of Cash Flow

5



Notes to Financial Statements

6



Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations

7



Item 3 - Controls and Procedures

8



PART II - OTHER INFORMATION

Item 1.  Legal Proceedings

8



Item 2.  Changes in Securities and Use of Proceeds

8



Item 3. Defaults Upon Senior Securities

8



Item 4. Submission of Matters to a Vote of Security Holders

8



Item 5. Other Information

8



Item 6. Exhibits and Reports on Form 8-K

9



SIGNATURES

9



CERTIFICATION

10































---

VIROPRO, INC.

FORM 10-QSB

SEPTEMBER 30, 2003



Part I - FINANCIAL INFORMATION



Item 1 - Financial Statements



VIROPRO, INC.

CONSOLIDATED BALANCE SHEET

(UNAUDITED)



|                                     |                                                      |                             |  |  |                    | 
|------------------------------------ | ---------------------------------------------------- | --------------------------- |  |  | ------------------ | 
|Assets                              
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  | September 30, 2003 | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|Current Assets                       | -                                                    |                            
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|                                     | Total current assets                                 | -                           | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|                                     | Total assets                                         | -                           | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|Liabilities and Shareholder's Equity
|                                     |                                                      |                             |  |  |                    | 
|Current Liabilities                  |                                                      |                            
|                                     | Accounts payable                                     | 8,130                       | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|                                     | Total current liabilities                            | 8,130                       | 
|                                     |                                                      |                             |  |  |                    | 
|                                     |                                                      |                             |  |  |                    | 
|Shareholder's Equity                 |                                                      |                            
|                                     | Common Stock, $.001 par value; authorized            | 49,975                      | 
|                                     | 50,000,000 shares; issued and outstanding 49,974,749 |                             | 
|                                     | Paid in Capital                                      | 1,913,950                   | 
|                                     | Accumulated Deficit                                  | (1,972,055)                 | 
|                                     |                                                      |                             |  |  |                    | 
|                                     | Total Shareholder's Equity/(Deficit)                 | (8,130)                     | 
|                                     |                                                      |                             |  |  |                    | 
|                                     | Total liabilities and shareholder's equity           | $                         - | 
|                                     |                                                      |                             |  |  |                    | 





Read the accompanying significant accounting notes to financial statements, which are an integral part of this financial statement.

---



VIROPRO, INC.

CONSOLIDATED STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002



|                                                         |                            |                            |                            |                            |  |  | Three months ended
|-------------------------------------------------------- | -------------------------- | -------------------------- | -------------------------- | -------------------------- |  |  | ------------------
|                                                         |                            |                            |                            |                            |  |  | September 30, 2003
|                                                         |                            |                            |                            |                            |  |  | (Unaudited)       
|                                                         |                            |                            |                            |                            |  |  |                   
|Revenue                                                  |                            | $                        - |                            | $                        -
|                                                         |                            |                            |                            |                            |  |  |                   
|Cost of Revenue                                          |                            | -                          |                            | -                         
|                                                         |                            |                            |                            |                            |  |  |                   
|Gross Profit                                             |                            | -                          |                            | -                         
|                                                         |                            |                            |                            |                            |  |  |                   
|Operating expenses:                                      |                            |                            |                            |                           
|Selling, general and administrative expenses             |                            | 500                        |                            | -                         
|Total operating expenses                                 |                            | 500                        |                            | -                         
|                                                         |                            |                            |                            |                            |  |  |                   
|Income(Loss) before other income (expense)               |                            | (500)                      |                            | -                         
|                                                         |                            |                            |                            |                            |  |  |                   
|Other income (expense):                                  |                            |                            |                            |                           
|Interest expense (principally related party)             |                            | -                          |                            | (14,580)                  
|Total other income (expense)                             |                            | -                          |                            | (14,580)                  
|                                                         |                            |                            |                            |                            |  |  |                   
|Income (Loss) from continuing operations                 |                            | (500)                      |                            | (14,580)                  
|                                                         |                            |                            |                            |                            |  |  |                   
|Discontinued operations:                                 |                            |                            |                            |                           
|Gain on assignment of subsidiary                         |                            | -                          |                            | -                         
|Income (Loss) from operations of discontinued subsidiary | -                          |                            | -                         
|                                                         |                            |                            |                            |                            |  |  | -                 
|                                                         |                            |                            |                            |                            |  |  |                   
|Net Income (Loss)                                        | (500)                      |                            | (14,580)                  
|                                                         |                            |                            |                            |                            |  |  |                   
|Basic weighted average common shares outstanding         | 49,974,749                 |                            | 7,474,749                 
|                                                         |                            |                            |                            |                            |  |  |                   
|Basic and diluted Loss per common share                  | $                   (0.00) |                            | $                   (0.00)
|                                                         |                            |                            |                            |                            |  |  |                   

























Read the accompanying significant accounting notes to financial statements, which are an integral part of this financial statement.



---

VIROPRO, INC.

STATEMENT OF CASH FLOWS

FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002





|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|------------------------------------------------------------ | ---------------------------------------- | --------------------------- | --------------------------- | -------------------------- |  |  | ------------------ | ------------------ | -----------
|                                                             |                                          |                             |                             |                            |  |  | Three months ended
|                                                             |                                          |                             |                             |                            |  |  | September 30, 2003 | September 30, 2002
|                                                             |                                          |                             |                             |                            |  |  | (Unaudited)        |                    | (Unaudited)
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|CASH FLOWS FROM OPERATING ACTIVITIES:                        |                                          |                             |                             |                           
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Net Income (Loss)                                            |                                          | $                     (500) |                             | $                 (14,580)
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Changes in Operating assets and liabilities:                 |                                          |                             |                             |                           
|                                                             | Accounts Payable and Accrued Liabilities | 500                         |                             | 14,580                    
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Net cash provided by/(used in) operating activities          | -                                        |                             | -                          
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|CASH FLOWS FROM INVESTING ACTIVITIES:                        |                                          |                             |                            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Net cash provided by/(used in) investing activities          | -                                        |                             | -                          
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|CASH FLOWS FROM FINANCING ACTIVITIES:                        |                                          |                             |                            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Net cash provided by/(used in) financing activities          | -                                        |                             | -                          
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Net increase (decrease) in cash and cash equivalents         | -                                        |                             | -                          
|Cash and cash equivalents, beginning of period               | -                                        |                             | -                          
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Cash and cash equivalents, end of period                     | $                         -              |                             | $                         -
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Supplemental information:                                    |                                          |                             |                            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|Pymt by shareholder of accounts payable on behalf of Company | (2,500)                                  |                             |                            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            
|                                                             |                                          |                             |                             |                            |  |  |                    |                    |            



















Read the accompanying significant accounting notes to financial statements, which are an integral part of this financial statement.



---

VIROPRO INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)





NOTE 1 BASIS OF PRESENTATION



The accompanying unaudited consolidated financial statements of Viropro, Inc. have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-QSB and Article 10 of Regulation S-X.  The financial statements reflect all adjustments consisting of normal recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown.  Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements.



These financial statements should be read in conjunction with the audited financial statements and footnotes thereto included in Viropro Inc.s form 10-KSB as filed with the Securities and Exchange Commission.



The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and that effect the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.



NOTE 2  NET EARNINGS/(LOSS) PER SHARE



Earnings (Loss) per common share are calculated under the provisions of SFAS No. 128, Earnings per Share, which establishes standards for computing and presenting earnings per share.  SFAS No. 128 requires the Company to report both basic earnings (loss) per share, which is based on the weighted-average number of common shares outstanding during the period, and diluted earnings (loss) per share, which is based on the weighted-average number of common shares outstanding plus all potential dilutive common shares outstanding.  Options and warrants are not considered in calculating diluted earnings (loss) per share since considering such items would have an anti-dilutive effect.



NOTE 3  GOING CONCERN



The accompanying financial statements have been prepared assuming the Company will continue as a going concern.  The company has reported net losses from inception totaling $1,972,055 (unaudited). Continuation of the Company as a going  concern is  dependent  upon  obtaining sufficient  working  capital for its planned activity.  Additional capital and/or borrowings will be necessary in order for the Company to continue in existence until attaining and sustaining profitable operations.  The Company is aggressively pursuing strategic alliances which will bring a cash infusion, restructuring and a forward looking business plan.



NOTE 4 -RELATED PARTY TRANSACTIONS



In September 2003 a major shareholder controlled entity, paid $2,500 of the Companys accounts payable on behalf of the Company.  The Company and the shareholder agreed to reflect this transaction as additional paid in capital to the Company.















---

VIROPRO, INC.

FORM 10-QSB

September 30, 2003



ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.



RESULTS OF OPERATIONS THREE MONTHS ENDED SEPTEMBER 30, 2003 AND 2002.





During the three month period ending September 30, 2003, the Companys net loss was $500 compared to a loss of $14,580 for the same period in the prior year.   The change from year to year was related to no interest accrued in the current quarter due to issuance of shares which settled a related party debt.  Gross profit for the three-month periods ended March 31, 2003 and 2002 was zero dollars.



REVENUES



During the three month periods ended September 30 2003 and 2002, the Company's revenues were zero dollars. Revenues were previously derived from the sale of the insecticide products sold under the Insecta Brand name. Revenues were recognized when the product sold was shipped to the Company's customer. The absence of revenue from year to year is due to the Company ceasing its business operations due to the EPA changing the applicable regulations covering the sale and distribution of products containing the active ingredient in the Company's Insecta brand insecticide. As previously reported the Company was notified that effective December 2001 the active ingredient of its insecticide formulation could no longer be sold.



OPERATING EXPENSES



During the three months ended September 30, 2003 and 2002 the Company incurred $500 in 2003 and zero in 2003 for operating expenses. This reflects the above-mentioned cessation of business due to changes in EPA regulations.



MATERIAL CHANGES IN FINANCIAL CONDITION, LONGEVITY AND CAPITAL RESOURCES.



At September 30, 2003, the Company had $0 in cash and cash equivalents, the same as at the start of the fiscal year, July 01, 2003.



















---

VIROPRO, INC.

FORM 10-QSB

September 30, 2003



Item 3. Controls and Procedures



Within the 90 days prior to the date of this report, the company carried out an evaluation, under the supervision and with the participation of the companys management, including the companys principal executive officer and principal financial officer, of the effectiveness of the design and operation of the companys disclosure controls and procedures pursuant to Exchange Act Rule 13a-14.  Based upon that evaluation, the principal executive officer and principal financial officer concluded that the companys disclosure controls and procedures are effective in timely alerting them to material information relating to the company required to be included in the companys periodic SEC filings.



PART II - OTHER  INFORMATION



Item  1.  Legal Proceedings.



None



Item  2.  Changes in Securities.



On March 7, 2003 the Board of the Company voted to approve the issuance of 42,500,000 shares of common stock  in conversion of an aggregate of $861,366 in loans due and owing on December 31, 2002.  This loan was converted at a rate per share of double the bid price for the common stock of the Company as of the date of the conversion.  None of the recipients of the shares was an affiliate prior to the conversion.



Item 3.  Defaults Upon Senior Securities.



None.



Item  4.  Submission of Matters to a Vote of Security-Holders.



None



Item  5.  Other Information.



None



Item  6.  Exhibits and Reports on Form 8-K.



(a)      Omitted exhibits not required.



(b)      Reports  on  Form  8-K



The Company filed no reports on 8-K during the period covered by this report.









---



SIGNATURE



In  accordance  with  the requirements of the Security Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, duly  authorized.



VIROPRO, INC.





Date: November 11, 2003

By: /s/ Hugh Johnson

--------------------------------

Hugh Johnson, President